Irreversible electroporation to treat aberrant cell masses
dc.contributor.assignee | Virginia Tech Intellectual Properties, Inc. | en |
dc.contributor.inventor | Robertson, John L. | en |
dc.contributor.inventor | Davalos, Rafael V. | en |
dc.contributor.inventor | Garcia, Paulo A. | en |
dc.contributor.inventor | Rossmeisl, John H. Jr. | en |
dc.contributor.inventor | Neal, II, Robert E. | en |
dc.date.accessed | 2016-08-19 | en |
dc.date.accessioned | 2016-08-24T17:55:23Z | en |
dc.date.available | 2016-08-24T17:55:23Z | en |
dc.date.filed | 2009-06-24 | en |
dc.date.issued | 2015-03-31 | en |
dc.description.abstract | The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. The invention can be used to treat solid tumors, such as brain tumors. The methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.applicationnumber | 12491151 | en |
dc.identifier.patentnumber | 8992517 | en |
dc.identifier.uri | http://hdl.handle.net/10919/72750 | en |
dc.identifier.url | http://pimg-fpiw.uspto.gov/fdd/17/925/089/0.pdf | en |
dc.language.iso | en_US | en |
dc.publisher | United States Patent and Trademark Office | en |
dc.subject.cpc | A61B18/1477 | en |
dc.subject.cpc | A61B18/1206 | en |
dc.subject.cpc | A61N1/327 | en |
dc.subject.cpc | A61B2018/00446 | en |
dc.subject.cpc | A61B2018/00613 | en |
dc.subject.cpc | A61N1/05 | en |
dc.subject.cpc | C12N13/00 | en |
dc.subject.uspc | 606/41 | en |
dc.subject.uspcother | 606/32 | en |
dc.title | Irreversible electroporation to treat aberrant cell masses | en |
dc.type | Patent | en |
dc.type.dcmitype | Text | en |
dc.type.patenttype | utility | en |
Files
Original bundle
1 - 1 of 1